natgillin/translations-raw huggingface dataset:
It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
STOT SE3; H335: C ≥ 5 %
Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;
1B; H314: 0,2 % ≤ C < 10 %
[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present.
2; H315: 0,02 % ≤ C < 0,2 %
It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.
2; H319: 0,02 % ≤ C < 0,2 %
This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]
STOT SE 3; H335: C ≥0,02 %
Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;
STOT RE 2; H373: C ≥0,05 %
[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed.
Repr.2 H361f: C ≥ 2,5 %
It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
STOT RE 2; H373: C ≥0,5 %
Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;
C U
[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed.
C S U
It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
D U
Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;
STOT SE 3; H335: C ≥ 25 %
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities.
STOT RE 2; H373: C ≥ 5 %
Extracts (petroleum), light paraffinic distillate solvent, clay-treated;
STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 %
[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities.
C D
It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
STOT RE 2; H373: C ≥ 0,005 %
Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;
A C
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities.
1B; H350: C ≥ 0,01 % STOT SE 3; H335:C≥5 %
It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
H319: C ≥ 25 %
Extracts (petroleum), light vacuum gas oil solvent, clay-treated;
1A; H350: C ≥ 0,001 %
[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities.
STOT SE 3; H335: C ≥10 %
It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 %
Foots oil (petroleum); Foots oil;
2; H315: 25 %≤ C < 50 %
[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process.
1B; H314: C ≥ 3 %
It consists predomi nantly of branched chain hydro carbons having carbon numbers predominantly in the range of C20 through C50.]
Skin Irrit.2; H315: C ≥5 %
Foots oil (petroleum), hydrotreated; Foots oil
1B; H350: C ≥1 %
turpentine, oil
1B; H314: C ≥25 % Skin Irrit.
fenson (ISO);
STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2 %
4-chlorophenyl benzenesulphonate;
B, D
norbormide (ISO);
STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5 %
5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicycle [2.2.1] hept-5-ene-2,3-dicarboximide
1A; H314: C ≥ 90 % Skin Corr.
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone
1B; H314: 10 % ≤ C < 90 %
benquinox (ISO);
1A; H314: C ≥90 % Skin Corr.
chlordimeform (ISO);
2; H315: 10 % ≤C <25 %
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine
1B; H314: C ≥ 2 % Skin Irrit.
drazoxolon (ISO);
2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 %
4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone
1; H317: C ≥ 0,2 %
chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;
2; H319 10 % ≤ C < 25 %
N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride
B D
Mineral wool, with the exception of those specified elsewhere in this Annex;
611-020-00-X
H319: 22 % ≤ C < 36 %
E Flam.
1B; H314: 10 % ≤ C < 50 %
613-090-00-7 parakvaatdikloriid; 1,1-dimetüül-4,4'-bipüridiiniumdikloriid; [1] parakvaatdimetüülsulfaat;
1; H334: C ≥ 0,2 %
613-128-00-2 prokloraas (ISO);
1; H317:C ≥0,2 %
613-129-00-8 metamitroon (ISO);
1; H317: C ≥ 0,5 %
613-138-00-7 kinoksüfeen (ISO);
1; H317:C ≥ 0,5 %
613-140-00-8 tsükloheksimiid (ISO);
H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 %
1-(3,4-diklorofenüülimino)tiosemikarbasiid
029-001-00-4 copper chloride;
3,3'-dioktadetsüül-1,1'-metüleenbis(4,1-fenüleen)dikarbamiid
029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)
205-793-9 151-56-4 Flam.
1B; H314: C ≥ 40 % Skin Irrit.
Liq.
STOT RE 2; H373: C ≥ 0,1 %
järgmiste lähteainete reaktsiooni saadus: difenüülmetaandiisotsüanaat, oktüülamiin ja oleüülamiin (moolsuhe 1: 1,86 : 0,14)
C D
maneeb (ISO);
1B; H314: C ≥ 50 % Skin Irrit.
649-416-00-X destillaadid (nafta), katalüütiliselt krakitud raskete tõrvade kergkeev fraktsioon;
Commission Implementing Regulation (EU) 2018/670
Komisjoni rakendusmäärus (EL) 2018/670,
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bromuconazole, buprofezin, haloxyfop-P and napropamide
millega muudetakse rakendusmäärust (EL) nr 540/2011 seoses toimeainete bromukonasooli, buprofesiini, haloksüfop-P ja napropamiidi heakskiidu kehtivusaja pikendamisega
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular the first paragraph of Article 17 thereof,
võttes arvesse Euroopa Parlamendi ja nõukogu 21. oktoobri 2009. aasta määrust (EÜ) nr 1107/2009 taimekaitsevahendite turulelaskmise ja nõukogu direktiivide 79/117/EMÜ ja 91/414/EMÜ kehtetuks tunnistamise kohta, eriti selle artikli 17 esimest lõiku,
Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.
Komisjoni rakendusmääruse (EL) nr 540/2011 lisa A osas on esitatud toimeained, mida loetakse määruse (EÜ) nr 1107/2009 kohaselt heakskiidetuks.
The approval periods of the substances haloxyfop-P and napropamide will expire on 31 December 2020.
Toimeainete haloksüfop-P ja napropamiidi heakskiidu kehtivusaeg lõpeb 31. detsembril 2020.
The approval periods of the substances bromuconazole and buprofezin will expire on 31 January 2021.
Toimeainete bromukonasooli ja buprofesiini heakskiidu kehtivusaeg lõpeb 31. jaanuaril 2021.
Applications for the renewal of the approval of the active substances included in this Regulation were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012.
Käesoleva määrusega hõlmatud toimeainete heakskiidu pikendamise taotlused esitati vastavalt komisjoni rakendusmäärusele (EL) nr 844/2012.
It is therefore necessary to extend their approval periods in accordance with Article 17 of Regulation (EC) No 1107/2009.
Seepärast on vaja pikendada kõnealuste ainete heakskiidu kehtivusaega kooskõlas määruse (EÜ) nr 1107/2009 artikliga 17.
In view of the time and resources necessary for completing the assessment of applications for renewal of approvals of large number of active substances the approvals of which are expiring between 2019 and 2021, Commission Implementing Decision C(2016)6104 established a work programme grouping together similar active substances and setting priorities on the basis of safety concerns for human and animal health or the environment as provided for in Article 18 of Regulation (EC) No 1107/2009.
Arvestades aega ja ressursse, mida on vaja suure arvu 2019.–2021. aastal lõppeva heakskiidu kehtivusajaga toimeainete heakskiidu pikendamise taotluste hindamiseks, loodi komisjoni rakendusotsusega C(2016) 6104 tööprogramm, milles rühmitatakse samalaadsed toimeained ja seatakse prioriteedid selle põhjal, millised on nendega seotud ohud inimeste ja loomade tervisele või keskkonnale, nagu on ette nähtud määruse (EÜ) nr 1107/2009 artikliga 18.
As the active substances included in this Regulation do not fall in the prioritised categories of Implementing Decision C(2016)6104, their approval period should be extended by either two or three years, taking into account the current date of expiry, the fact that in accordance with Article 6(3) of Implementing Regulation (EU) No 844/2012 the supplementary dossier for an active substance is to be submitted no later than 30 months before expiry of the approval, the need to ensure a balanced distribution of responsibilities and work among Member States acting as rapporteurs and co-rapporteurs and the available resources necessary for assessment and decision-making.
Kuna käesoleva määruse alla kuluvad toimeained ei kuulu rakendusotsuses C(2016) 6104 esitatud prioriteetsetesse kategooriatesse, tuleks nende heakskiidu kehtivusaega pikendada kahe või kolme aasta võrra, võttes arvesse kehtivaid aegumistähtaegu, nõuet esitada toimeainete täiendavad toimikud vastavalt rakendusmääruse (EL) nr 844/2012 artikli 6 lõikele 3 hiljemalt 30 kuud enne heakskiidu kehtivusaja lõppu, vajadust tagada referent- ja kaasreferentliikmesriikide vahel ülesannete ja töö ühtlane jaotamine, samuti hindamiseks ja otsustamiseks vajalike ressursside olemasolu.
It is therefore appropriate to extend the approval period for the active substance buprofezin by two years, and to extend the approval periods of the active substances bromuconazole, haloxyfop-P and napropamide by three years.
Seepärast on asjakohane pikendada toimeaine buprofesiini heakskiidu kehtivusaega kahe aasta võrra ning toimeainete bromukonasooli, haloksüfop-P ja napropamiidi heakskiidu kehtivusaega kolme aasta võrra.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
Arvestades määruse (EÜ) nr 1107/2009 artikli 17 esimese lõigu eesmärki nende juhtumite puhul, kui komisjon võtab vastu määruse, milles sätestatakse, et käesoleva määruse lisas viidatud toimeaine heakskiitu ei pikendata, kuna heakskiitmise tingimused ei ole täidetud, määrab komisjon kehtivusaja lõpu samale kuupäevale, mis kehtis enne käesoleva määruse kohaldamist, või kuupäevale, mil jõustub määrus, milles sätestatakse, et toimeaine heakskiitu ei pikendata, olenevalt sellest, kumb kuupäev on hilisem.
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation
Rakendusmääruse (EL) nr 540/2011 lisa A osa muudetakse käesoleva määruse lisa kohaselt.
Done at Brussels, 30 April 2018.
Brüssel, 30. aprill 2018
Commission Implementing Decision of 28 September 2016 on the establishment of a work programme for the assessment of applications for the renewal of approvals of active substances expiring in 2019, 2020 and 2021 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council (OJ C 357, 29.9.2016, p. 9).
Komisjoni 28. septembri 2016. aasta rakendusotsus, millega kehtestatakse tööprogramm 2019., 2020. või 2021. aastal lõppeva kehtivusajaga toimeainete heakskiidu pikendamise taotluste hindamiseks vastavalt Euroopa Parlamendi ja nõukogu määrusele (EÜ) nr 1107/2009 (ELT C 357, 29.9.2016, lk 9).
in the sixth column, expiration of approval, of row 309, Haloxyfop-P, the date is replaced by ‘31 December 2023’;
reas asendatakse haloksüfop-P-d käsitleva kande kuuendas veerus („Heakskiitmise aegumine“) kuupäev järgmisega „31. detsember 2023“;
in the sixth column, expiration of approval, of row 310, Napropamide, the date is replaced by ‘31 December 2023’;
reas asendatakse napropamiidi käsitleva kande kuuendas veerus („Heakskiitmise aegumine“) kuupäev järgmisega „31. detsember 2023“;
in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘31 January 2024’;
reas asendatakse bromukonasooli käsitleva kande kuuendas veerus („Heakskiitmise aegumine“) kuupäev järgmisega „31. jaanuar 2024“;
in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘31 January 2023’.
reas asendatakse buprofesiini käsitleva kande kuuendas veerus („Heakskiitmise aegumine“) kuupäev järgmisega „31. jaanuar 2023“.
Commission Implementing Regulation (EU) 2018/671
Komisjoni rakendusmäärus (EL) 2018/671,
making imports of electric bicycles originating in the People's Republic of China subject to registration
millega kehtestatakse Hiina Rahvavabariigist pärit elektrijalgrataste impordi registreerimise nõue
Having regard to Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union (‘the basic anti-dumping Regulation’), and in particular Article 14(5) thereof,
võttes arvesse Euroopa Parlamendi ja nõukogu 8. juuni 2016. aasta määrust (EL) 2016/1036 kaitse kohta dumpinguhinnaga impordi eest riikidest, mis ei ole Euroopa Liidu liikmed (edaspidi „dumpinguvastane alusmäärus“), eriti selle artikli 14 lõiget 5,
Having regard to Regulation (EU) 2016/1037 of the European Parliament and of the Council of 8 June 2016 on protection against subsidised imports from countries not members of the European Union (‘the basic anti-subsidy Regulation’), and in particular Article 24(5) thereof,
võttes arvesse Euroopa Parlamendi ja nõukogu 8. juuni 2016. aasta määrust (EL) 2016/1037 kaitse kohta subsideeritud impordi eest riikidest, mis ei ole Euroopa Liidu liikmed (edaspidi „subsiidiumivastane alusmäärus“), eriti selle artikli 24 lõiget 5,
On 20 October 2017, the European Commission (‘the Commission’) announced, by a notice published in the Official Journal of the European Union (‘the AD notice of initiation’), the initiation of an anti-dumping proceeding (‘the anti-dumping proceeding’) with regard to imports into the Union of electric bicycles originating in the People's Republic of China (‘PRC’) following a complaint lodged on 8 September 2017 by the European Bicycle Manufacturers Association (‘the complainant’ or ‘EBMA’) on behalf of producers representing more than 25 % of the total Union production of electric bicycles.
20. oktoobril 2017 teatas Euroopa Komisjon (edaspidi „komisjon“) Euroopa Liidu Teatajas avaldatud teates (edaspidi „dumpinguvastase menetluse algatamise teade“) dumpinguvastase menetluse algatamisest Hiina Rahvavabariigist (edaspidi „HRV“) pärit elektrijalgrataste impordi suhtes pärast seda, kui Euroopa jalgrattatootjate ühendus (edaspidi „kaebuse esitaja“ või „EBMA“) oli 8. septembril 2017 esitanud kaebuse nende tootjate nimel, kelle arvele langeb üle 25 % elektrijalgrataste toodangust kogu liidus.
On 21 December 2017, the Commission announced, by a notice published in the Official Journal of the European Union (‘the AS notice of initiation’), the initiation of an anti-subsidy proceeding (‘the anti-subsidy proceeding’) with regard to imports into the Union of electric bicycles originating in the PRC following a complaint lodged on 8 November 2017 by the complainant on behalf of producers representing more than 25 % of the total Union production of electric bicycles.
21. detsembril 2017 teatas Euroopa Komisjon Euroopa Liidu Teatajas avaldatud teates (edaspidi „subsiidiumivastase menetluse algatamise teade“) subsiidiumivastase menetluse algatamisest HRVst pärit elektrijalgrataste impordi suhtes pärast seda, kui kaebuse esitaja oli 8. novembril 2017 esitanud kaebuse tootjate nimel, kelle arvele langeb üle 25 % elektrijalgrataste toodangust kogu liidus.
The product subject to registration (‘the product concerned’) for both proceedings is cycles, with pedal assistance, with an auxiliary electric motor, originating in the PRC, currently falling within CN codes 87116010 and ex87116090 (TARIC code 8711609010).
Registreerimisele kuuluva toote (edaspidi „vaatlusalune toode“) puhul on mõlemas menetluses tegemist pedaalidega ja elektrilise abimootoriga jalgratastega, mis pärinevad HRVst ning kuuluvad praegu CN-koodide 87116010 ja ex87116090 (TARICi kood 8711609010) alla.
These CN and TARIC codes are given for information only.
Need CN-koodid ja TARICi koodid on esitatud ainult teavitamise eesmärgil.
The complainant indicated in its complaints its intention to request registration.
Kaebuse esitaja väljendas oma kaebuses kavatsust taotleda registreerimist.
On 31 January 2018, the complainant submitted registration requests pursuant to Article 14(5) of the basic anti-dumping Regulation and Article 24(5) of the basic anti-subsidy Regulation.
31. jaanuaril 2018 esitas kaebuse esitaja registreerimistaotlused vastavalt dumpinguvastase alusmääruse artikli 14 lõikele 5 ja subsiidiumivastase alusmääruse artikli 24 lõikele 5.
The complainant requested that imports of the product concerned be made subject to registration so that measures may subsequently be applied against those imports from the date of such registration, provided all conditions set out in the basic Regulations are met.
Kaebuse esitaja nõudis, et kehtestataks vaatlusaluse toote impordi registreerimise nõue, et edaspidi saaks kõnealuse impordi suhtes kohaldada meetmeid alates impordi registreerimise kuupäevast, kui on täidetud kõik alusmääruses sätestatud tingimused.
According to Article 14(5) of the basic anti-dumping Regulation and Article 24(5) of the basic anti-subsidy Regulation, the Commission may direct the customs authorities to take the appropriate steps to register imports, so that measures may subsequently be applied against those imports from the date of such registration, provided all conditions set out in the basic Regulations are met.
Vastavalt dumpinguvastase alusmääruse artikli 14 lõikele 5 ja subsiidiumivastase alusmääruse artikli 24 lõikele 5 võib komisjon anda tolliasutustele korralduse võtta asjakohaseid meetmeid impordi registreerimiseks, et selle impordi suhtes saaks seejärel alates registreerimiskuupäevast neid meetmeid kohaldada, kui on täidetud kõik alusmääruses sätestatud tingimused.
Imports may be made subject to registration following a request from the Union industry, which contains sufficient evidence to justify such action.
Impordi registreerimise nõude võib kehtestada pärast liidu tootmisharu sellekohast taotlust, mis sisaldab piisavalt tõendusmaterjali, mis õigustab sellise meetme võtmist.
According to the complainant, registration is justified as the product concerned is being dumped and subsidised.
Kaebuse esitaja väitis, et registreerimine on õigustatud, sest vaatlusalust toodet müüakse dumpinguhinnaga ja subsideeritakse.
Significant injury to the Union industry, is being caused by an acceleration of low-priced imports which will undermine the remedial effect of potential definitive duties by allowing stockpiling ahead of the 2018 selling season.
Märkimisväärne kahju liidu tootmisharule tuleneb madala hinnaga impordi suurenemisest, mis kahjustab võimalike lõplike tollimaksude leevendavat mõju, võimaldades varuda lattu tooteid enne 2018. aasta müügihooaega.
The Commission examined the request in the light of Article 10(4) of the basic anti-dumping Regulation and Article 16(4) of the basic anti-subsidy Regulation.
Komisjon vaatas taotluse läbi, võttes arvesse dumpinguvastase alusmääruse artikli 10 lõiget 4 ja subsiidiumivastase alusmääruse artikli 16 lõiget 4.
With respect to the dumping part of the request, the Commission verified whether the importers were aware, or should have been aware, of the dumping as regards the extent of the dumping and the injury alleged or found.
Taotluse dumpinguosa puhul kontrollis komisjon, kas importijad olid või oleksid pidanud olema dumpingu kestusest ja väidetavast või kindlakstehtud kahjust teadlikud.
With respect to the subsidy part of the request, the Commission verified whether there are critical circumstances where, for the subsidised product in question, injury which is difficult to repair is caused by massive imports in a relatively short period of a product benefitting from countervailable subsidies and whether it is deemed necessary to assess countervailing duties retroactively on those imports in order to preclude the recurrence of such injury.
Taotluse subsideerimisosa puhul kontrollis komisjon, kas taotlus sisaldab tõendeid kriitiliste asjaolude kohta, mille puhul tasakaalustatavast subsiidiumist kasu saav vaatlusaluse toote massiline import on suhteliselt lühikese aja jooksul tekitanud raskesti heastatavat kahju, ning kas sellise kahju kordumise vältimiseks peetakse vajalikuks määrata sellele impordile tagasiulatuvalt tasakaalustav tollimaks.
As regards dumping, at this stage, the Commission has at its disposal sufficient evidence that imports of the product concerned from the PRC are being dumped.
Seoses dumpinguga on komisjonil selles etapis piisavalt tõendeid selle kohta, et HRVst imporditud vaatlusalust toodet müüakse dumpinguhinnaga.
In particular, the complainant provided evidence on the normal value based on domestic prices and based on the choice of Switzerland according to Article 2(7) of the basic anti-dumping Regulation.
Kaebuse esitaja edastatud tõendite aluseks on eelkõige normaalväärtus, mis põhineb siseriiklikel hindadel ja Šveitsi valimisel võrdlusriigiks vastavalt dumpinguvastase alusmääruse artikli 2 lõikele 7.
The evidence of dumping is based on a comparison of the normal value thus established with the export price (at ex-works level) of the product concerned when sold for export to the Union.
Tõendid dumpingu kohta põhinevad niimoodi kindlaks määratud normaalväärtuse võrdlusel liitu ekspordiks müüdava vaatlusaluse toote ekspordihinnaga (tehasehindade tasemel).
As a whole, and given the extent of the alleged dumping margins ranging from 193 % to 430 %, this evidence provides sufficient support at this stage that the exporting producers practice dumping.
Võttes aga arvesse väidetavate dumpingumarginaalide suurust (vahemikus 193–430 %), kinnitavad esitatud tõendid praeguses etapis piisavalt seda, et eksportivad tootjad kasutavad dumpingut.
That information was contained in the notice of initiation for this proceeding published on 20 October 2017.
See teave esitati menetluse algatamise teates 20. oktoobril 2017.
Giant, an exporting producer with a related importer, claimed that the initiation of an anti-dumping investigation was not sufficient to establish awareness of dumping.
Seotud importijaga eksportiv tootja Giant väitis, et dumpinguvastase uurimise alustamisest ei piisa selleks, et olla dumpingust teadlik.
By its publication in the Official Journal of the European Union, the notice of initiation is a public document accessible to all importers.
Algatamisteade on pärast Euroopa Liidu Teatajas avaldamist avalik dokument, mis on kõigile importijatele kättesaadav.